Patient info Open main menu

Aqueous cream BP – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Medicine status: General sale (GSL) Details

Medicine strength:
690 mg/gram + 150 mg/gram + 90 mg/gram + 60 mg/gram + 10 mg/gram
Contains active substances:

Summary of Product Characteristics (SmPC) - Aqueous cream BP

1 NAME OF THE MEDICINAL PRODUCT

Aqueous Cream B.P.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient% w/w
White Soft Paraffin BP Liquid Paraffin BP15.0 6.0

Excipient(s) with known effect

This product contains sodium lauryl sulfate, cetostearyl alcohol and chlorocresol, see section 4.4.

For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Cream.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

For topical application to the skin:

As an emollient for the symptomatic relief of dry skin conditions. As a soap-substitute for skin washing

4.2 Posology and method of administration

Adults, children and elderly:

To be applied to the skin as required.

4.3. Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

For external use only.

Paediatric population

An audit of children attending a paediatric dermatology clinic recorded the proportion of immediate cutaneous reactions to emollients (defined as one or more of burning, stinging, itching and redness developing within 20 minutes of application). Aqueous cream was the emollient used by most (71%), which was associated with an immediate cutaneous reaction in 56% of exposures, compared with 18% with other emollients used (details of the other emollients were not reported; n = 100).

Fire Safety Warning

Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.

Slip Hazard Warning

This preparation may make skin and surfaces slippery – particular care is needed when bathing.

Excipient Warnings

Aqueous cream contains sodium lauryl sulfate which may cause local skin reactions (such as stinging or burning sensation) or increase skin reactions caused by other products when applied on the same area, particularly in children with atopic eczema.

Aqueous cream contains cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis).

Aqueous cream contains chlorocresol which may cause allergic reactions.

Keep all medicines out of the sight and reach of children.

4.5. Interactions with other medicinal products and other forms of interaction

No clinically significant drug interactions known.

4.6. Pregnancy and lactation

The safety of aqueous cream during pregnancy and lactation has nor been established but is not considered to constitute a hazard during these periods.

4.7. Effects on ability to drive and use machines

No adverse effects known.

4.8 Undesirable effects

Occasional allergic reactions.

Aqueous cream may be associated with immediate cutaneous reactions when used as a leave-on emollient, such as stinging, burning, itching and redness. See section 4.4.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Symptoms of accidental oral ingestion may include gastrointestinal symptoms, particularly diarrhoea. Treatment need only be symptomatic.

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic properties

White soft paraffin and liquid paraffin have emollient properties.

5.2. Pharmacokinetic properties

None applicable.

5.3. Preclinical safety data

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Emulsifying wax (contains cetostearyl alcohol and sodium lauryl sulfate) Chlorocresol

Purified water

6.2. Incompatibilities

Not applicable.

6.3. Shelf life

36 months.

6.4. Special precautions for storage

Tub: Store in a cool place.

Tube: None

6.5 Nature and contents of container

Polypropylene jar with an unlined polypropylene cap. Pack size: 500g

or Polypropylene securitub with a white pilfer-proof cap. Pack size: 500g

or Pigmented LDPE/HDPE tube fitted with a polypropylene screw cap Pack sizes: 60g 100g

or Laminate tube fitted with a polypropylene screw cap. Pack sizes: 60g, 100g

6.6 Special precautions for disposal

Not applicable

7 MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

Trading as: BCM

8. MARKETING AUTHORISATION NUMBER

PL: 00014/5202R.

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

First Authorisation: 16th December 1986. Renewal: 16th December 1991.

10 DATE OF REVISION OF THE TEXT

12/02/2024

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00014/5202

Last revision stated in the text: 12 February 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Aqueous cream BP

Prescription needed? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substances Liquid paraffin, White soft paraffin, Purified water, Emulsifying wax, Phenoxyethanol
Strength 690 mg/gram + 150 mg/gram + 90 mg/gram + 60 mg/gram + 10 mg/gram
Pharmaceutical form Cutaneous cream
How is it taken Cutaneous
Excipients Emulsifying wax (contains cetostearyl alcohol and sodium lauryl sulfate) Chlorocresol, Purified water
Pack sizes 500 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Marketing authorisation PL 00014/5202 (first authorised 16 December 1986)
Marketing authorisation holder The Boots Company PLC
Codes GTIN 5045098593107 · BNF 13020101

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.